DaVita Clinical Research (DCR), a specialty CRO based in Minneapolis, has expanded its clinical trials capabilities in Europe. DCR now will be able to facilitate the conduct of late phase clinical trials in several medical centers outside of the U.S. Physician leaders from Germany, Poland and Portugal, with a combined 20 years of research experience, will collaborate with DCR to provide data and knowledge-based insights to its clients.

DCR has been involved in developing every end stage renal disease drug approved by the FDA in the last 15 years. Individuals with advanced kidney disease typically have co-morbidities, which may cause health complications. Clinical research is a necessary step in providing high-quality care to patients with impaired kidney function.

DCR has conducted phase I clinical trials in the U.S. since 1985, expanding its capabilities to include late phase clinical research, real-world health care data, health economics and outcomes research and medical communications over the past 30 years.